|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 11400 TOMAHAWK CREEK PARKWAY |
Address2 |
|
| City | LEAWOOD |
State | KS |
Zip Code | 66211-2672 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 1342-12
|
||||||||
|
6. House ID# 321800000
|
||||||||
| TYPE OF REPORT | 8. Year | 2016 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Lisa R. Westergaard |
Date | 1/19/2017 12:15:12 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
S. 3040; HR 5926 - HHS FY 17 Appropriations priorities: AHRQ, HRSA, Title VII, NHSC, Title X, CARA: AAFP federal spending priorities for primary care training research and access.
No Bill No. - FY2018 appropriations for HRSA Title VII 747: AAFP federal spending priorities for primary care training research and access.
No Bill No - FY 2016 appropriations AHRQ, HRSA, Title VII, NHSC: AAFP Federal spending priorities to support workforce, research.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
S. 3040; HR 5926 - HHS FY 17 Appropriations priorities: AHRQ, HRSA, Title X, NHSC, Title X, CARA: AAFP federal spending priorities for primary care training research and access.
HR 899: Teaching Health Center Graduate Medical Education: Increasing primary care workforce; maintain the stability of the THCGME program.
No Bill No.-Graduate Medical Education: Express AAFP's overall GME reform policies to Congress; Advocate for members to co-sponsor a Resolution to support stability in the Teaching Health Center GME program; Support for Teaching Health Center reauthorization.
No Bill No. - FY2018 appropriations for HRSA Title VII 747: Primary Care Training and Enhancement Grants.
No Bill No. - National Health Service Corps trust fund and appropriated funding: Increased level of medical student debt relief, improved access to primary care.
No Bill No - FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research.
No Bill No. - Congressional Primary Care Caucus - Urge members to join the Caucus and support Primary Care to achieve the triple aim in health care.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Sonya |
Clay |
|
|
|
Robert |
Hall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 3040; HR 5926 - HHS FY 17 Appropriations priorities: AHRQ, HRSA, Title VII, NHSC, Title X, CARA: AAFP federal spending priorities for primary care training research and access.
Cures (HR 6) and Mental Health Reform Bill (HR 2646); Support for health IT interoperability, mental health integration and mental health parity.
HR 6 - Cures: Engagement on the Cures bill and key primary care provisions.
HR 899: Teaching Health Center Graduate Medical Education permanance: Increasing primary care workforce; maintain the sustainability of the THCGME program.
PL 114-198 - Comprehensive Addiction and Recovery Act: Support, advocate investment in PDMPs, treatment, naloxone.
No Bill No.-Graduate Medical Education: Express AAFP's overall GME reform policies to Congress; Advocate for members to co-sponsor a Resolution to support stability in the Teaching Health Center GME program; Support for Teaching Health Center reauthorization; maintain the sustainability of the THCGME program.
No Bill No. - Physician Payment Reform: Advocate for introduction of a House companion bill to allow HSA population access to direct primary care (DPC); advocate for bill to remove Part B co-insurance for Medicare CCM code (99490); advocate for expansion and further development of PCMH and CPC+.
No Bill No. - Physician payment reform under Medicare: Defense and modification of MACRA and its payment models.
No Bill No. - Congressional Primary Care Caucus: Urge Members to join the Caucus and support the Primary Care to achieve the triple aim in health care; Increased membership in Primary Care Caucus.
No Bill No. - FY2018 appropriations for HRSA Title VII 747: AAFP federal spending priorities for primary care training research and access.
No Bill No. - Tour of the Centers for Disease Control and Prevention: Promoting Public Health.
No Bill No. - Affordable Care Act: Urge for health care coverage for all.
No Bill No. - National Advisory Council on the National Health Service Corps: Medical student debt relief, improved access to primary care.
No Bill No. - Zika Funding Request: prompt action on public health emergency.
No Bill No. - Letter to CMS on 2018 marketplaces: How exchanges should cover primary care services.
No Bill No. - Letter to HHS on Title X: re: coverage for family planning.
No Bill No. - Letter to HHS nominating Family Physicians: Advisory Committee on Minority Health.
No Bill No. - Letter to PTAC on payment models: How APMs should be structured.
No Bill No. - Letter to DOT on PCPs and diabetic drivers: Allowing PCPs to do exams on commercial drivers.
No Bill No. - Letter to HRSA with nominations: childhood vaccine nominees.
No Bill No. - Letter to SSA on medical evidence: what is covered as a disability.
No Bill No. - Letter to FDA on sodium reduction: sodium reduction goals.
No Bill No. - Letter to CDC on ACIP nominations: re: immunizations.
No Bill No. - Letter to FDA on tobacco nominations: nomination of FP to FDA tobacco committee.
No Bill No. - Letter to VA nominating for rural health: FP nomination.
No Bill No. - Letter to CMS on MACRA final rule: MACRA physician payments.
No Bill No. - Letter to HHS on tobacco FAQ: tobacco cessation FAQ.
No Bill No. - Letter to CMS on outpatient 2017 final rule: site of service neutrality.
No Bill No. - Letter to CMS on patient relationship codes: MACRA required codes.
No Bill No. - Letter to HHS on vaccine report: vaccine terms and studies.
No Bill No. - Letter to CMS on final medicare rule: re administrative simplification and payment.
No Bill No. - Health IT/Interoperability/Cures: Support for health IT interoperability legislation.
No Bill No. - Mental Health reform: Support mental health reform integration and mental health parity.
No Bill No. - US Preventative Services Task Force: Support for maintaining USPSTF integrity.
No Bill No. - Preventative Health and Primary Care: HELP Committee preparation for the HHS Secretary nomination and 115th Congress.
No Bill No - FY 2016 appropriations AHRQ, HRSA Title VII, NHSC: AAFP Federal spending priorities to support workforce, research.
No Bill No. - Remove national licensure provisions in the NDAA legislation health provisions.
No Bill No. - Health Insurance Marketplace Issues and Provider Involvement with Patient Enrollment: Network Adequacy, Patient Enrollment in Marketplaces.
No Bill No. - Children's Health Insurance: CHIP/Medicaid.
No Bill No. - Medicaid: Medicaid alternative proposals.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC), White House Office, Centers For Medicare and Medicaid Services (CMS), Transportation - Dept of (DOT), Health Resources & Services Administration (HRSA), Social Security Administration (SSA), Food & Drug Administration (FDA), Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
|
|
Shannon |
Morey |
|
|
|
Sonya |
Clay |
|
|
|
Robert |
Hall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Cures (HR 6) and Mental Health Reform Bill (HR 2646); Support for health IT interoperability, mental health integration and mental health parity.
HR 6 - Cures: Engagement on the Cures bill and key primary care provisions.
HR 899: Teaching Health Center Graduate Medical Education permanance: Increasing primary care workforce; maintain the sustainability of the THCGME program.
No Bill No.-Graduate Medical Education: Express AAFP's overall GME reform policies to Congress; Advocate for members to co-sponsor a Resolution to support stability in the Teaching Health Center GME program.
No Bill No. - Physician Payment Reform: Advocate for introduction of a House companion bill to allow HSA population access to direct primary care (DPC); advocate for bill to remove Part B co-insurance for Medicare CCM code (99490); advocate for expansion and further development of PCMH and CPC+.
No Bill No. - Congressional Primary Care Caucus: Urge Members to join the Caucus.
No Bill No. - Tour of the Centers for Disease Control and Prevention: Promoting Public Health.
No Bill No. - Letter to PTAC on payment models: How APMs should be structured.
No Bill No. - Letter to CMS on MACRA final rule: MACRA physician payments.
No Bill No. - Letter to HHS on tobacco FAQ: tobacco cessation FAQ.
No Bill No. - Letter to CMS on outpatient 2017 final rule: site of service neutrality.
No Bill No. - Letter to CMS on patient relationship codes: MACRA required codes.
No Bill No. - Letter to CMS on 2017 final medicare rule: re administrative simplification and payment.
No Bill No. - Mental Health reform: Support mental health reform integration and mental health parity.
No Bill No. - US Preventative Services Task Force: Support for maintaining USPSTF integrity.
No Bill No. - Preventative Health and Primary Care: HELP Committee preparation for the HHS Secretary nomination and 115th Congress.
No Bill No. - Congressional Primary Care Caucus - Urge members to join the Caucus and support Primary Care to achieve the triple aim in health care.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
|
Andrew |
Adair |
|
|
|
Teresa |
Baker |
|
House Legislative Assistant, Analyst, and Director |
|
Robert |
Bennett |
|
|
|
Sonya |
Clay |
|
|
|
Robert |
Hall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code ALC
16. Specific lobbying issues
Comprehensive Addiction & Recovery Act - PL 114-198: Support advocate investment in state prescription drug monitoring, treatment, naloxone.
No Bill No. - Tour of the Centers for Disease Control and Prevention: Promoting Public Health.
17. House(s) of Congress and Federal agencies Check if None
Health & Human Services - Dept of (HHS), White House Office, U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Teresa |
Baker |
|
House Legislative Assistant, Analyst & Director |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Cures (HR 6) and Mental Health Reform Bill (HR 2646); Support for health IT interoperability, mental health integration and mental health parity.
HR 6 - Cures: Engagement on the Cures bill and key primary care provisions.
No Bill No. - Mental Health reform: Support mental health reform integration and mental health parity.
No Bill No. - US Preventative Services Task Force: Support for maintaining USPSTF integrity.
No Bill No. - Preventative Health and Primary Care: HELP Committee preparation for the HHS Secretary nomination and 115th Congress.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sonya |
Clay |
|
|
|
Mark |
Cribben |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
No Bill No. - National Defense Authorization Act: Remove national licensure provisions in NDAA legislation health provisions.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
No Bill No. - National Defense Authorization Act: Remove national licensure provisions in NDAA legislation health provisions.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Mark |
Cribben |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code SCI
16. Specific lobbying issues
No Bill No. - Health IT/Interoperability/Cures: Support for Health IT and interoperability legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Sonya |
Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |